WA
OACC

Whitebox Advisors’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Whitebox Advisors’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67M Hold
250,000
– – 0.04% 245
2026
Q1 		$2.65M Hold
250,000
– – 0.03% 204
2025
Q4 		$2.65M Hold
250,000
– – 0.04% 185
2025
Q3 		$2.63M Hold
250,000
– – 0.04% 177
2025
Q2 		$2.61M Buy
+250,000
New +$2.59M 0.05% 166

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BGGS
Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Whitebox Advisors's OACC Position: Q2 2026 in Review

Whitebox Advisors held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q2 2026 at 250,000 shares worth $2.67M. The position accounts for 0.04% of the portfolio, ranked #245.

Whitebox Advisors first reported a position in OACC in Q2 2025 and has held it in 5 quarters since. 51 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

  • Whitebox Advisors held 250,000 shares of Oaktree Acquisition Corp III Life Sciences worth $2.67M as of Q2 2026.
  • Whitebox Advisors left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q2 2026.
  • Oaktree Acquisition Corp III Life Sciences made up 0.04% of Whitebox Advisors's portfolio in Q2 2026, its #245 holding.
  • Whitebox Advisors first reported a position in Oaktree Acquisition Corp III Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on Whitebox Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.